UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 719,725 shares of the healthcare conglomerate's stock after acquiring an additional 44,801 shares during the period. UnitedHealth Group accounts for about 1.1% of Nomura Asset Management Co. Ltd.'s investment portfolio, making the stock its 11th biggest position. Nomura Asset Management Co. Ltd. owned approximately 0.08% of UnitedHealth Group worth $364,080,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of UNH. Broadway Wealth Solutions Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth $570,000. New Age Alpha Advisors LLC lifted its stake in UnitedHealth Group by 147,866.7% in the fourth quarter. New Age Alpha Advisors LLC now owns 31,073 shares of the healthcare conglomerate's stock valued at $15,719,000 after acquiring an additional 31,052 shares during the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $6,375,744,000. LM Advisors LLC raised its stake in UnitedHealth Group by 10.4% in the 4th quarter. LM Advisors LLC now owns 4,953 shares of the healthcare conglomerate's stock valued at $2,506,000 after acquiring an additional 465 shares during the period. Finally, Homestead Advisers Corp bought a new position in UnitedHealth Group during the fourth quarter worth $28,429,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 0.0 %

UnitedHealth Group stock traded down $0.25 during mid-day trading on Friday, hitting $515.47. The company had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The company has a market capitalization of $471.51 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock's 50 day moving average price is $508.81 and its two-hundred day moving average price is $544.24.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 EPS. The firm's revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.